知镜 Cognispect · 医学文献与研究工作台

Appropriateness of antiphospholipid antibody testing and its impact on diagnostic yield and clinical outcomes: a multicentre cohort study.

Natarajan R, Shrestha P, Elliott K, Partha Sarathy P.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis · 2026-11-06 · PMID 42895315

文献摘要

Objective Antiphospholipid syndrome (APS) is an uncommon but important cause of thrombosis and pregnancy morbidity. Despite guidelines, antiphospholipid antibody (aPL) testing is frequently performed outside specialist settings, potentially reducing diagnostic yield and leading to unnecessary downstream investigations. We evaluated real-world aPL testing practices, diagnostic yield, and clinical outcomes. Methods We conducted a retrospective cohort study across three acute hospitals, two satellite sites and 63 general practices between February and June 2024. Adults undergoing aPL testing (anticardiolipin, β2-glycoprotein-I or lupus anticoagulant) were identified from electronic pathology records. Appropriateness, completeness, results and downstream clinical outcomes were assessed against BSH/EULAR guidance and the documented clinical context. Results Among 691 patients tested (mean age 51.3 years; 67% women), only 34% requests were considered appropriate, and complete panels were requested in 26%. APS was confirmed in 14 patients (2%). Appropriate requests were associated with higher rates of positive results [risk ratio (RR) 2.39], APS diagnosis (RR 27.0) and management changes (RR 21.4) (all P Conclusion Antiphospholipid antibody testing is frequently performed outside recommended clinical indications, resulting in low overall diagnostic yield. Appropriate testing is associated with improved diagnostic accuracy and clinically meaningful changes in patient management, supporting the implementation of targeted diagnostic stewardship interventions.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。